Concepedia

Author

James E. Herndon

Duke University Hospital

Also Known As

J E Herndon, James E. Herndon

5

Publications

436

Citations

4

H-Index

19

Concepts

All Affiliations

Duke University HospitalDuke Medical CenterDuke University
JE

About

James E. Herndon is an author at Duke University Hospital specializing in medicine, pharmacotherapy, and cancer therapeutics.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

2

2

94

2

Natural Sciences

1

1

25

3

Chemical Biology

1

1

25

4

Molecular Biology

1

1

25

5

Pharmacology

1

1

25

James E. Herndon

×

4

Publications

436

Citations

4

H-Index

YearCitations

Phase I trial of O6-benzylguanine for patients undergoing surgery for malignant glioma.

H. S. Friedman, Demetrius M. Kokkinakis, James M. Pluda,

Journal of Clinical Oncology

1998

216

Quality of life for adult leukemia survivors treated on clinical trials of cancer and leukemia group B during the period 1971-1988

Alice B. Kornblith, James E. Herndon, Enid Zuckerman,

Cancer

1997

126

Dosimetry and dose–response relationships in newly diagnosed patients with malignant gliomas treated with Iodine-131-Labeled anti-tenascin monoclonal antibody 81C6 therapy

Gamal Akabani, Ilkcan Cokgor, Robert E. Coleman,

International Journal of Radiation Oncology*Biology*Physics

2000

69

Modulation of O6-alkylguanine-DNA alkyltransferase-mediated carmustine resistance using streptozotocin: a phase I trial.

Timothy J. Panella, David C. Smith, S. Clifford Schold,

PubMed

1992

25

Page 1